• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于报告人用药品、生物制品和器械严重不良事件及产品问题的表格;可获取性——美国食品药品监督管理局。通知。

Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.

出版信息

Fed Regist. 1993 Jun 3;58(105):31596-614.

PMID:10171452
Abstract

The Food and Drug Administration (FDA) is announcing the availability of a new form for reporting adverse events and product problems with human drug products, biologic products, medical devices (including in-vitro diagnostics), special nutritional products (dietary supplements, medical foods, infant formulas), and other products regulated by FDA. There are two versions of the form. One version of the form (FDA Form 3500) is available for use by health professionals for voluntary reporting; the other version of the form (FDA Form 3500A) is to be used by user facilities, distributors, and manufacturers for reporting that is required by statute or FDA regulations. The new form will simplify and consolidate the reporting of adverse events and product problems and will enhance agency-wide consistency in the collection of postmarketing data. This notice also responds to written comments the agency received on proposed versions of this form. Copies of both versions of the new form appear at the end of this document.

摘要

美国食品药品监督管理局(FDA)宣布推出一种新表格,用于报告人用药品、生物制品、医疗器械(包括体外诊断试剂)、特殊营养产品(膳食补充剂、医用食品、婴儿配方奶粉)以及FDA监管的其他产品的不良事件和产品问题。该表格有两个版本。其中一个版本(FDA表格3500)供医疗专业人员自愿报告使用;另一个版本(FDA表格3500A)供使用单位、经销商和制造商用于法规或FDA规定要求的报告。新表格将简化并整合不良事件和产品问题的报告,并提高全机构在上市后数据收集方面的一致性。本通知还回应了该机构收到的关于此表格草案版本的书面意见。新表格两个版本的副本均附于本文末尾。

相似文献

1
Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.用于报告人用药品、生物制品和器械严重不良事件及产品问题的表格;可获取性——美国食品药品监督管理局。通知。
Fed Regist. 1993 Jun 3;58(105):31596-614.
2
Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.《安全医疗器械法案》:医院遵守美国食品药品监督管理局新要求的管理指南
Hosp Technol Ser. 1993 Oct;12(11):1-27.
3
Improving patient care by reporting problems with medical devices.通过报告医疗设备问题来改善患者护理。
CRNA. 1998 Nov;9(4):139-56.
4
Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration--FDA. Tentative final rule.医疗器械;医疗器械、用户机构、经销商及制造商报告、认证和注册——美国食品药品监督管理局。暂行最终规则。
Fed Regist. 1991 Nov 26;56(228):60024-39.
5
Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.医疗器械;医疗器械经销商报告——美国食品药品监督管理局。最终规则;根据《安全医疗器械法案》通报状态;生效日期确认。
Fed Regist. 1993 Sep 1;58(168):46514-23.
6
Medical devices; device tracking; new orders to manufacturers--FDA. Notice.医疗器械;器械追踪;向制造商发出的新订单——美国食品药品监督管理局。通知。
Fed Regist. 1998 Mar 4;63(42):10638-40.
7
FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.1997年《食品药品监督管理局现代化法案》:医疗器械追踪指南;可用性——食品药品监督管理局。通知。
Fed Regist. 1998 Mar 4;63(42):10640-1.
8
Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.医疗器械报告:制造商报告、进口商报告、用户机构报告和经销商报告——美国食品药品监督管理局。直接最终规则。
Fed Regist. 1998 May 12;63(91):26069-77.
9
Dietary supplement adverse event reports: review and analysis.膳食补充剂不良事件报告:回顾与分析
Food Drug Law J. 2009;64(3):503-13.
10
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.1969 - 2002年美国药品不良事件监测与药物撤市:报告疑似不良反应的重要性
Arch Intern Med. 2005 Jun 27;165(12):1363-9. doi: 10.1001/archinte.165.12.1363.